Crinetics Pharmaceuticals, Inc. Annual Share-based Payment Arrangement, Expense in USD from 2016 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Crinetics Pharmaceuticals, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2016 to 2023.
  • Crinetics Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $18.9M, a 86.1% increase year-over-year.
  • Crinetics Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $55.1M, a 63.6% increase year-over-year.
  • Crinetics Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $40.9M, a 44.8% increase from 2022.
  • Crinetics Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $28.3M, a 62.9% increase from 2021.
  • Crinetics Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $17.4M, a 66.4% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $40.9M +$12.7M +44.8% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-28
2022 $28.3M +$10.9M +62.9% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-28
2021 $17.4M +$6.93M +66.4% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-28
2020 $10.4M +$4.13M +65.7% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-28
2019 $6.29M +$3.97M +171% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-30
2018 $2.32M +$2.05M +756% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-30
2017 $271K +$1K +0.37% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-09
2016 $270K Jan 1, 2016 Dec 31, 2016 10-K 2019-03-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.